Annual Current Ratio
9.93
-10.42-51.20%
31 December 2023
Summary:
XTL Biopharmaceuticals annual current ratio is currently 9.93, with the most recent change of -10.42 (-51.20%) on 31 December 2023. During the last 3 years, it has fallen by -14.17 (-58.80%). XTLB annual current ratio is now -69.34% below its all-time high of 32.39, reached on 31 December 2018.XTLB Current Ratio Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Ratio
11.43
+1.50+15.11%
31 March 2024
Summary:
XTL Biopharmaceuticals quarterly current ratio is currently 11.43, with the most recent change of +1.50 (+15.11%) on 31 March 2024. Over the past year, it has dropped by -2.66 (-18.88%). XTLB quarterly current ratio is now -77.62% below its all-time high of 51.07, reached on 01 March 2019.XTLB Quarterly Current Ratio Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
XTLB Current Ratio Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -51.2% | -18.9% |
| 3 y3 years | -58.8% | -67.3% |
| 5 y5 years | -69.3% | -71.1% |
XTLB Current Ratio High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -63.2% | at low | -67.3% | +15.1% |
| 5 y | 5 years | -69.3% | at low | -71.1% | +15.1% |
| alltime | all time | -69.3% | +331.7% | -77.6% | +5095.4% |
XTL Biopharmaceuticals Current Ratio History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2024 | - | 11.43(+15.1%) |
| Dec 2023 | 9.93(-51.2%) | 9.93(-29.5%) |
| Sept 2023 | - | 14.09(-8.1%) |
| June 2023 | - | 15.34(+25.6%) |
| Mar 2023 | - | 12.21(-40.0%) |
| Dec 2022 | 20.35(-24.6%) | 20.35(-31.1%) |
| Sept 2022 | - | 29.52(-5.6%) |
| June 2022 | - | 31.26(+30.3%) |
| Mar 2022 | - | 24.00(-11.1%) |
| Dec 2021 | 27.00(+12.0%) | 27.00(-22.8%) |
| Sept 2021 | - | 34.99(+37.4%) |
| June 2021 | - | 25.47(-7.8%) |
| Mar 2021 | - | 27.61(+14.6%) |
| Dec 2020 | 24.10(-18.1%) | 24.10(-24.7%) |
| Sept 2020 | - | 32.02(-3.1%) |
| June 2020 | - | 33.03(+17.0%) |
| Mar 2020 | - | 28.23(-4.1%) |
| Dec 2019 | 29.44(-9.1%) | 29.44(-25.5%) |
| Sept 2019 | - | 39.54(-12.4%) |
| June 2019 | - | 45.15(-11.6%) |
| Mar 2019 | - | 51.07(+57.7%) |
| Dec 2018 | 32.39(+56.5%) | 32.39(-10.0%) |
| Sept 2018 | - | 35.98(+17.6%) |
| June 2018 | - | 30.59(+17.3%) |
| Mar 2018 | - | 26.07(+26.0%) |
| Dec 2017 | 20.69(+147.8%) | 20.69(-8.2%) |
| Sept 2017 | - | 22.53(+26.7%) |
| June 2017 | - | 17.78(+30.6%) |
| Mar 2017 | - | 13.61(+63.0%) |
| Dec 2016 | 8.35(-14.6%) | 8.35(-33.0%) |
| June 2016 | - | 12.47(+27.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2015 | 9.78(+204.7%) | 9.78(-46.8%) |
| Sept 2015 | - | 18.39(-19.2%) |
| June 2015 | - | 22.76(+609.0%) |
| Dec 2014 | 3.21(-23.0%) | 3.21(-2.4%) |
| Sept 2014 | - | 3.29(+0.3%) |
| June 2014 | - | 3.28(-10.6%) |
| Mar 2014 | - | 3.67(-12.0%) |
| Dec 2013 | 4.17(+81.3%) | 4.17(-3.0%) |
| Sept 2013 | - | 4.30(+126.3%) |
| June 2013 | - | 1.90(-10.0%) |
| Mar 2013 | - | 2.11(-8.3%) |
| Dec 2012 | 2.30(-11.2%) | 2.30(-50.5%) |
| Sept 2012 | - | 4.65(+6.9%) |
| June 2012 | - | 4.35(+6.4%) |
| Mar 2012 | - | 4.09(+41.5%) |
| Sept 2011 | - | 2.89(-8.5%) |
| June 2011 | - | 3.16(+1.3%) |
| Mar 2011 | - | 3.12(+98.7%) |
| Sept 2010 | - | 1.57(+613.6%) |
| June 2010 | - | 0.22(-52.2%) |
| Mar 2010 | - | 0.46(-61.0%) |
| Sept 2009 | - | 1.18(-16.3%) |
| June 2008 | - | 1.41(-45.6%) |
| Dec 2007 | 2.59(-66.2%) | 2.59(-20.3%) |
| June 2007 | - | 3.25(-57.6%) |
| Dec 2006 | 7.67(+33.9%) | 7.67(-27.4%) |
| June 2006 | - | 10.57(+84.5%) |
| Dec 2005 | 5.73(-14.9%) | 5.73(-5.1%) |
| June 2005 | - | 6.04(-10.3%) |
| Dec 2004 | 6.73(-12.0%) | 6.73(+80.9%) |
| June 2004 | - | 3.72 |
| Dec 2003 | 7.65 | - |
FAQ
- What is XTL Biopharmaceuticals annual current ratio?
- What is the all time high annual current ratio for XTL Biopharmaceuticals?
- What is XTL Biopharmaceuticals annual current ratio year-on-year change?
- What is XTL Biopharmaceuticals quarterly current ratio?
- What is the all time high quarterly current ratio for XTL Biopharmaceuticals?
- What is XTL Biopharmaceuticals quarterly current ratio year-on-year change?
What is XTL Biopharmaceuticals annual current ratio?
The current annual current ratio of XTLB is 9.93
What is the all time high annual current ratio for XTL Biopharmaceuticals?
XTL Biopharmaceuticals all-time high annual current ratio is 32.39
What is XTL Biopharmaceuticals annual current ratio year-on-year change?
Over the past year, XTLB annual current ratio has changed by -10.42 (-51.20%)
What is XTL Biopharmaceuticals quarterly current ratio?
The current quarterly current ratio of XTLB is 11.43
What is the all time high quarterly current ratio for XTL Biopharmaceuticals?
XTL Biopharmaceuticals all-time high quarterly current ratio is 51.07
What is XTL Biopharmaceuticals quarterly current ratio year-on-year change?
Over the past year, XTLB quarterly current ratio has changed by -2.66 (-18.88%)